Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Sanofi image

Sanofi withdraws lixisenatide US application

September 12, 2013
Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa

In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …

News

GSK banks on bioelectronics with new fund

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …

News
GSK image

FDA makes GSK wait

August 6, 2013
Sales and Marketing FDA, GSK, albiglutide, diabetes

The FDA is making GlaxoSmithKline wait for a verdict on the manufacturer’s investigational type 2 diabetes treatment albiglutide, extending its …

News

Boehringer and partners launch digital diabetes study

July 19, 2013
Medical Communications Boehringer, Syrum, Twitter, diabetes, digital, type 2

Boehringer Ingelheim has partnered with Healthrageous and United BioSource to establish a new diabetes study to help patients manage their …

News
Roche image

Blow for Roche as it halts diabetes drug trial

July 10, 2013
Research and Development, Sales and Marketing Roche, aleglitazar, diabetes

Roche has stopped a late-stage trial of its investigational diabetes drug aleglitazar over safety concerns. The move was prompted by …

News
Vaccine image

Diabetes vaccine trial posts positive results

June 28, 2013
Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes

A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …

News
Lilly image

Lilly diabetes drug beats rivals

June 25, 2013
Sales and Marketing BMS, diabetes, dulaglutide, lilly

New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …

News
Medimmune image

MedImmune signs diabetes deal

June 18, 2013
Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes

AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …

News
Channel 4 image

Diabetes drug risks fuel transparency debate

June 12, 2013
Research and Development, Sales and Marketing BMJ, Channel 4, all trials, diabetes, transaprency

A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released …

News

Pfizer and Merck create major diabetes alliance

April 30, 2013
Research and Development, Sales and Marketing Merck, Pfizer, diabetes

Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …

News
lilly_corporate_hq

Lilly Phase III diabetes boost

April 17, 2013
Research and Development, Sales and Marketing diabetes, dulaglutide, lilly

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …

News

Merck KGaA/BMS China deal

March 22, 2013
Sales and Marketing BMS, Merck KGaA, diabetes

Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …

News
Victoza image

Underwhelming results for Victoza

March 20, 2013
Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …

News
janssen image

Janssen submits diabetes combination

March 12, 2013
Sales and Marketing Janssen, diabetes

Janssen has submitted a combination of its investigational diabetes drug canagliflozin with immediate-release metformin to the European Medicines Agency.The manufacturer, …

News

Sanofi celebrates EU approvals

February 5, 2013
Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes

Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026